| scholarly article | Q13442814 |
| P50 | author | Shanshan Shao | Q86873023 |
| Fei Jing | Q88550646 | ||
| P2093 | author name string | Xiaoqing Ma | |
| Chunxiao Yu | |||
| Wenhua Du | |||
| Lingyan Zhou | |||
| P2860 | cites work | Endoplasmic reticulum stress and the inflammatory basis of metabolic disease | Q24633352 |
| ER stress-induced cell death mechanisms | Q27027638 | ||
| Stress responses from the endoplasmic reticulum in cancer | Q28082709 | ||
| Liraglutide alleviates diabetic cardiomyopathy by blocking CHOP-triggered apoptosis via the inhibition of the IRE-α pathway. | Q51326848 | ||
| Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis. | Q53280450 | ||
| The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms. | Q54291953 | ||
| Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. | Q54627651 | ||
| Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats. | Q54632091 | ||
| Effect of Liraglutide on endoplasmic reticulum stress in diabetes. | Q54753987 | ||
| Finding new treatments for diabetes--how many, how fast... how good? | Q79701190 | ||
| Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways | Q28365886 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity | Q28728101 | ||
| Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease | Q29619334 | ||
| Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice | Q34718822 | ||
| Dipeptidyl petidase-IV inhibitor (gemigliptin) inhibits tunicamycin-induced endoplasmic reticulum stress, apoptosis and inflammation in H9c2 cardiomyocytes. | Q35166009 | ||
| Effect of vildagliptin on hepatic steatosis | Q35442079 | ||
| Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function | Q35630861 | ||
| Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | Q36183590 | ||
| Dipeptidyl peptidase-4: a key player in chronic liver disease | Q36783164 | ||
| Potential for therapeutic manipulation of the UPR in disease | Q36809416 | ||
| Glucagon-Like Peptide-1 Analog Liraglutide Protects against Diabetic Cardiomyopathy by the Inhibition of the Endoplasmic Reticulum Stress Pathway | Q36825702 | ||
| GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice | Q37170811 | ||
| Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. | Q37888004 | ||
| Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction | Q38069507 | ||
| Basic mechanisms in endoplasmic reticulum stress and relation to cardiovascular diseases | Q38276130 | ||
| MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice | Q38302500 | ||
| DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease | Q38376373 | ||
| Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy | Q38407023 | ||
| A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. | Q38841750 | ||
| Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice | Q39975807 | ||
| DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes | Q42906627 | ||
| Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes | Q43070817 | ||
| Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling | Q43073146 | ||
| Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis | Q43237637 | ||
| Involvement of endoplasmic reticulum stress in insulin resistance and diabetes | Q45127777 | ||
| Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs | Q45261151 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| P304 | page(s) | 5045182 | |
| P577 | publication date | 2018-03-12 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Vildagliptin Can Alleviate Endoplasmic Reticulum Stress in the Liver Induced by a High Fat Diet | |
| P478 | volume | 2018 |
| Q101564256 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression | cites work | P2860 |
Search more.